Community Oncology Connections™: Optimizing SCLC Treatment Strategies and Managing Adverse Events Across Disease Stages | North Carolina

Release Date: January 7, 2026

Expiration Date: February 11, 2026

Activity Overview

Targeted and immunologic therapies are continuing to transform the treatment landscape for patients with small cell lung cancer (SCLC) across all disease settings. In recent years, the characterization of novel treatment approaches has led to fundamental shifts in how these tumors are managed, and therapies directed against new targets have shown substantial activity.

This Community Oncology Connections™ program is a series of live online meetings focused on providing community oncologists with the latest updates to the management of SCLC, including discussions of novel approaches to maintenance therapy, immunotherapy, and the emerging role of novel targeted therapies across the treatment landscape.

This educational activity is an archive of the live presentation held on December 19, 2025.

Target Audience

This educational program is primarily directed toward community-based oncologists involved in the treatment of SCLC.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

• Discuss current trial data describing novel strategies for the management of limited- and extensive-stage SCLC
• Plan strategies to prevent and proactively manage treatment-related adverse events in patients with SCLC
• Apply clinical trial evidence supporting the efficacy and safety of SCLC treatment strategies to optimally manage patients with SCLC in the second- and subsequent-line setting